Cargando…

Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis

BACKGROUND & AIMS: Iron reduction by venesection has been the cornerstone of treatment for haemochromatosis for decades, and its reported health benefits are many. Repeated phlebotomy can lead to a compensatory increase in intestinal iron absorption, reducing intestinal iron availability. Given...

Descripción completa

Detalles Bibliográficos
Autores principales: Parmanand, Bhavika, Watson, Michael, Boland, Karen J., Ramamurthy, Narayan, Wharton, Victoria, Morovat, Alireza, Lund, Elizabeth K., Collier, Jane, Le Gall, Gwenaelle, Kellingray, Lee, Fairweather-Tait, Susan, Cobbold, Jeremy F., Narbad, Arjan, Ryan, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516344/
https://www.ncbi.nlm.nih.gov/pubmed/32995714
http://dx.doi.org/10.1016/j.jhepr.2020.100154
_version_ 1783586987815469056
author Parmanand, Bhavika
Watson, Michael
Boland, Karen J.
Ramamurthy, Narayan
Wharton, Victoria
Morovat, Alireza
Lund, Elizabeth K.
Collier, Jane
Le Gall, Gwenaelle
Kellingray, Lee
Fairweather-Tait, Susan
Cobbold, Jeremy F.
Narbad, Arjan
Ryan, John D.
author_facet Parmanand, Bhavika
Watson, Michael
Boland, Karen J.
Ramamurthy, Narayan
Wharton, Victoria
Morovat, Alireza
Lund, Elizabeth K.
Collier, Jane
Le Gall, Gwenaelle
Kellingray, Lee
Fairweather-Tait, Susan
Cobbold, Jeremy F.
Narbad, Arjan
Ryan, John D.
author_sort Parmanand, Bhavika
collection PubMed
description BACKGROUND & AIMS: Iron reduction by venesection has been the cornerstone of treatment for haemochromatosis for decades, and its reported health benefits are many. Repeated phlebotomy can lead to a compensatory increase in intestinal iron absorption, reducing intestinal iron availability. Given that most gut bacteria are highly dependent on iron for survival, we postulated that, by reducing gut iron levels, venesection could alter the gut microbiota. METHODS: Clinical parameters, faecal bacterial composition and metabolomes were assessed before and during treatment in a group of patients with haemochromatosis undergoing iron reduction therapy. RESULTS: Systemic iron reduction was associated with an alteration of the gut microbiome, with changes evident in those who experienced reduced faecal iron availability with venesection. For example, levels of Faecalibacterium prausnitzii, a bacterium associated with improved colonic health, were increased in response to faecal iron reduction. Similarly, metabolomic changes were seen in association with reduced faecal iron levels. CONCLUSION: These findings highlight a significant shift in the gut microbiome of patients who experience reduced colonic iron during venesection. Targeted depletion of faecal iron could represent a novel therapy for metabolic and inflammatory diseases, meriting further investigation. LAY SUMMARY: Iron depletion by repeated venesection is the mainstay of treatment for haemochromatosis, an iron-overload disorder. Venesection has been associated with several health benefits, including improvements in liver function tests, reversal of liver scarring, and reduced risk of liver cancer. During iron depletion, iron absorption from the gastrointestinal (GI) tract increases to compensate for iron lost with treatment. Iron availability is limited in the GI tract and is crucial to the growth and function of many gut bacteria. In this study we show that reduced iron availability in the colon following venesection treatment leads to a change in the composition of the gut bacteria, a finding that, to date, has not been studied in patients with haemochromatosis.
format Online
Article
Text
id pubmed-7516344
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75163442020-09-28 Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis Parmanand, Bhavika Watson, Michael Boland, Karen J. Ramamurthy, Narayan Wharton, Victoria Morovat, Alireza Lund, Elizabeth K. Collier, Jane Le Gall, Gwenaelle Kellingray, Lee Fairweather-Tait, Susan Cobbold, Jeremy F. Narbad, Arjan Ryan, John D. JHEP Rep Short Communication BACKGROUND & AIMS: Iron reduction by venesection has been the cornerstone of treatment for haemochromatosis for decades, and its reported health benefits are many. Repeated phlebotomy can lead to a compensatory increase in intestinal iron absorption, reducing intestinal iron availability. Given that most gut bacteria are highly dependent on iron for survival, we postulated that, by reducing gut iron levels, venesection could alter the gut microbiota. METHODS: Clinical parameters, faecal bacterial composition and metabolomes were assessed before and during treatment in a group of patients with haemochromatosis undergoing iron reduction therapy. RESULTS: Systemic iron reduction was associated with an alteration of the gut microbiome, with changes evident in those who experienced reduced faecal iron availability with venesection. For example, levels of Faecalibacterium prausnitzii, a bacterium associated with improved colonic health, were increased in response to faecal iron reduction. Similarly, metabolomic changes were seen in association with reduced faecal iron levels. CONCLUSION: These findings highlight a significant shift in the gut microbiome of patients who experience reduced colonic iron during venesection. Targeted depletion of faecal iron could represent a novel therapy for metabolic and inflammatory diseases, meriting further investigation. LAY SUMMARY: Iron depletion by repeated venesection is the mainstay of treatment for haemochromatosis, an iron-overload disorder. Venesection has been associated with several health benefits, including improvements in liver function tests, reversal of liver scarring, and reduced risk of liver cancer. During iron depletion, iron absorption from the gastrointestinal (GI) tract increases to compensate for iron lost with treatment. Iron availability is limited in the GI tract and is crucial to the growth and function of many gut bacteria. In this study we show that reduced iron availability in the colon following venesection treatment leads to a change in the composition of the gut bacteria, a finding that, to date, has not been studied in patients with haemochromatosis. Elsevier 2020-07-28 /pmc/articles/PMC7516344/ /pubmed/32995714 http://dx.doi.org/10.1016/j.jhepr.2020.100154 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Parmanand, Bhavika
Watson, Michael
Boland, Karen J.
Ramamurthy, Narayan
Wharton, Victoria
Morovat, Alireza
Lund, Elizabeth K.
Collier, Jane
Le Gall, Gwenaelle
Kellingray, Lee
Fairweather-Tait, Susan
Cobbold, Jeremy F.
Narbad, Arjan
Ryan, John D.
Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
title Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
title_full Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
title_fullStr Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
title_full_unstemmed Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
title_short Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
title_sort systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516344/
https://www.ncbi.nlm.nih.gov/pubmed/32995714
http://dx.doi.org/10.1016/j.jhepr.2020.100154
work_keys_str_mv AT parmanandbhavika systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT watsonmichael systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT bolandkarenj systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT ramamurthynarayan systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT whartonvictoria systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT morovatalireza systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT lundelizabethk systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT collierjane systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT legallgwenaelle systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT kellingraylee systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT fairweathertaitsusan systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT cobboldjeremyf systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT narbadarjan systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis
AT ryanjohnd systemicironreductionbyvenesectionaltersthegutmicrobiomeinpatientswithhaemochromatosis